Physician profile
Craig Basman
NPI 1316246622
$66,702.53
in general payments reported to CMS, 2019-2025
34 companies · $23K in 2025
The $23K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $2,080 · 2021: $2,466 · 2022: $1,781 · 2023: $4,151 · 2024: $6,774 · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $20K · Food and Beverage: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $20,106.86 |
| Food and Beverage | $14,015.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23,839.94 | 2021-2025 | Corevalve Evolut R, Ffrangio, Micra |
| Medtronic Vascular, INC. | $21,071.94 | 2019-2020 | |
| Edwards Lifesciences Corporation | $7,982.55 | 2019-2025 | Sapien 3 Ultra Resilia, Evoque, Pascal |
| Abbott Laboratories | $4,238.98 | 2019-2025 | Cardiomems, Mitraclip, Navitor |
| Boston Scientific Corporation | $1,823.85 | 2019-2025 | Accolade Sr, General - Therapies, Watchman Flx |
| Cardiovascular Systems INC. | $1,222.31 | 2019-2021 | |
| Abiomed | $1,142.56 | 2019-2025 | Impella |
| Inari Medical, INC. | $970.25 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $592.61 | 2019-2020 | |
| Cardiva Medical, INC. | $399.96 | 2023-2025 | Savvywire, Cardiva Vascade 6/7f Vcs |
| W. L. Gore & Associates, INC. | $348.32 | 2019-2025 | Gore Cardioform Septal Occluder, Gore Septal Occluder |
| Shockwave Medical, INC | $325.59 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $282.08 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $274.15 | 2019-2024 | Artis Icono Floor, Naeotom Alpha |
| E.R. Squibb & Sons, L.L.C. | $223.07 | 2022-2023 | Camzyos |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $210.00 | 2019 | |
| Amgen INC. | $200.29 | 2021-2023 | Repatha |
| Pfizer INC. | $176.96 | 2020-2025 | |
| Teleflex LLC | $170.71 | 2023-2024 | Manta |
| Penumbra, INC. | $150.36 | 2021 | |
| Bolton Medical INC | $149.11 | 2020 | |
| Heartflow, INC. | $144.98 | 2021 | |
| Ancora Heart, INC. | $138.25 | 2024 | Accucinch |
| Astrazeneca Pharmaceuticals Lp | $134.07 | 2021 | |
| Janssen Pharmaceuticals, INC | $116.02 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $82.59 | 2019-2022 | |
| Cardiac Dimensions, INC. | $67.99 | 2024-2025 | |
| Haemonetics Corporation | $50.26 | 2024-2025 | Teg6s Hemostasis System |
| Ethicon US, LLC | $35.47 | 2025 | Vistaseal, Dermabond Prineo, Evarrest |
| Angiodynamics, INC. | $34.29 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.99 | 2020 | |
| Acist Medical Systems, INC. | $24.67 | 2024 | |
| Chiesi USA, INC. | $24.65 | 2019 | |
| Irhythm Technologies, INC. | $19.71 | 2023 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$142.69 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Basman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.